Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Aug 30, 2023

BUY
$0.45 - $0.86 $109,665 - $209,582
243,700 New
243,700 $126,000
Q4 2022

Feb 13, 2023

SELL
$0.45 - $0.86 $18,356 - $35,081
-40,793 Reduced 14.34%
243,700 $126,000
Q3 2022

Nov 14, 2022

SELL
$0.46 - $0.63 $9,295 - $12,730
-20,207 Reduced 6.63%
284,493 $128,000
Q2 2022

Aug 15, 2022

BUY
$0.47 - $0.87 $76,661 - $141,905
163,110 Added 115.2%
304,700 $177,000
Q1 2022

May 16, 2022

BUY
$0.75 - $1.77 $106,192 - $250,614
141,590 New
141,590 $112,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Atria Wealth Solutions, Inc. Portfolio

Follow Atria Wealth Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.